Seizure disorders in mutant mice: Relevance to human epilepsies

Current Opinion in Neurobiology

Volumn 9, Issue 3, 1999, Pages 281-287

  Puranam, Ram S ^a   McNamara, James O ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CHANNEL GATING; EPILEPSY; EPILEPTOGENESIS; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENETIC LINKAGE; GENOTYPE; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEIZURE;

EID: 0033153256     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(99)80041-5     Document Type: Article

References (61)

1. Commission on Classification and Terminology of the International League against Epilepsy: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
2. Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, Ronen GM, Bjerre I, Quattlebaum T, Murphy JV et al.: A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. War Genef 1998, 18:25-29. This paper presents strong genetic data implicating a mutated ion channel gene in human epilepsy. The authors identified a novel potassium channel gene, KCNQ2, that is mutated in BFNCs (specifically EBN1: epilepsy benign neonatal 1).
3. Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ, Leppert M: A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genef 1998, 18:53-55. On the basis of the findings by Singh et al. [2••] and the presence of a second locus for BFNC (EBN2), the authors looked for a homologous gene to the BFNC (EBN1) potassium channel. This led to the discovery of a second, novel potassium channel involved in BFNC.
4. Bievert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ, Steinlein OK: A potassium channel mutation in neonatal human epilepsy. Science 1998, 279:403-406. This work further extends the findings presented in [2••1 and shows that in a large pedigree with BFNC (EBN1), the same potassium channel is mutated.
5. + channel β1 subunit gene SCN1B. Nat Genet 1998, 19:366-370. This publication is the first example of a mutation in a sodium channel causing a disease of the human nervous system. This is also a first example of a disease resulting from a mutation in a regulatory β subunit. This paper further strengthens the theme that idiopathic epilepsies are a family of channelopathies.
6. des Portes V, Pinard JM, Billuart P, Vinet MC, Koulakoff A, Carrie A, Gelot A, Dupuis E, Motte J, Netter YB et al.: A novel CMS gene required for neuronal migration and involved in X- Linked subcortical laminar heterotopia and lissencephaly syndrome. Cell 1998, 92:51-61.
7. Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer I, Cooper EC, Dobyns WB, Minnerath SR, Ross ME, Walsh CA: Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998, 92:63-72.
8. Fox JW, Lamperti ED, Eksioglu YZ, Hong SE, Feng Y, Graham DA, Scheffer IE, Dobyns WB, Hirsch BA, Radtke RA et al.: Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 1998, 21:1315-1325.
9. Minassian BA, Lee JR, Herbrick JA, Huizenga J, Soder S, Mungall AJ, Dunham I, Gardner R, Fong CYG, Carpenter S et al.: Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 1998, 20:171-174.
10. McNamara JO: Genetics of epilepsy. In Molecular Neurology. Edited by Martin JB. New York City: Scientific American Press; 1999:75-93.
11. Steinlein OK, Mulley JC, Propping P, Wallace RH, Phillips HA, Sutherland GR, Scheffer IE, Berkovic SF: A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant frontal lobe epilepsy. Nat Gene 1995, 11:201-203.
12. Baraban SC, Hollopeter G, Erickson JG, Schwartzkroin PA, Palmiter RD: Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 1997, 17:8927-8936.
13. Rosahl TW, Spillane D, Missler M, Herz J, Selig DK, Wolff JR, Hammer RE, Malenka RC, Sudhof TC: Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 1995, 375:488-493.
14. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T et al.: Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
15. Waymire KG, Mahuren JD, Jaje M, Guilarte TR, Coburn SP, MacGregor GR: Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 1995, 11:45-51.
16. Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, Baekkeskov S: Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 1997, 94:14060-14065.
17. Homanics GE, DeLorey TM, Firestone LL, Quinlan JJ, Handforth A, Harrison NL, Krasowski MD, Rick CE, Korpi ER, Makela R et al.: Mice devoid of gamma-aminobutyrate type A receptor betas subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 1997, 94:4143-4148.
18. a-receptor delta (δ) subunits [abstract]. Epilepsia 1997, 38(suppl 8):123.
19. Brusa R, Zimmerman F, Koh DS, Feldmeyer D, Gass P, Seeburg PH, Sprengel R: Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995, 270:1677-1680.
20. Tecott RH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D: Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995, 374:542-546.
21. v1.1 potassium channel causes epilepsy in mice. Neuron 1998, 20:809-819. This publication demonstrates that deletion of a potassium channel in mice leads to frequent spontaneous seizures throughout adult life. Mutations in the same gene in humans cause episodic ataxia/myokymia, but no seizures. This signifies the differences in the phenotype between humans and mice, possibly attributable to the nature of the mutation (or to species differences in its localization) or to expression or function of the potassium channel gene.
22. Kearney JA, Plummer N, Smith MR, Kapur J, Goldin AL, Meisler MH: Seizures in transgenic mice associated with expression of a mutated sodium channel with altered inactivation kinetics. Soc Neurosci Abstr 1998, 24:1 820.
23. + channel GIRK2. Proc Natl Acad Sci USA 1997, 94:923-927.
24. 2+/calmodulin-dependent kinase II alpha-subunit mutation. Proc Natl Acad Sci USA 1995, 92:6852-6855.
25. Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M et al.: Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 1996, 379:168-171.
26. Aigner L, Arber S, Kapfhammer JP, Laux T, Schneider C, Botteri F, Brenner HR, Caroni P: Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 1995, 83:269-278.
27. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH: Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997, 18:29-42.
28. Acampora D, Mazan S, Avantaggiato V, Barone P, Tuorto F, Lallem Y, Brulet P, Simeone A: Epilepsy and brain abnormalities in mice lacking the Otx1 gene. Nat Gene 1996, 14:218-222.
29. Toth M, Grimsby J, Buzsaki G, Donovan GP: Epileptic seizures caused by inactivation of a novel gene, jerky, related to centromere binding protein-B in transgenic mice. Nat Genet 1995, 11:71-75.
30. Kim E, Lowenson JD, MacLaren CD, Clarke S, Young SG: Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc Natl Acad Sci USA 1997, 94:6132-6137.
31. Yamamoto A, Takagi H, Kitamura D, Tatsuoka H, Nakano H, Kawano H, Kuroyanagi H, Yahagi Y, Kobayashi S, Koizumi K et al: Deficiency in protein L-isoaspartyl methyltransferase results in a fatal progressive epilepsy. J Neurosci 1998, 18:2063-2074.
32. Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, Skop E, Starr CM, Hoffman A, Sandhoff K, Suzuki K, Praia RL: Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet 1996, 14:348-352.
33. Pennacchio LA, Bouley DM, Higgins KM, Scott MP, Noebels JL, Myers RM: Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Gent 1998, 20:251-258. This paper reports an animal model of epilepsy created by targeting the gene implicated in Unverricht-Lundborg disease (EPM1), a progressive myoclonic epilepsy in humans. The animal phenotype parallels the human disease and demonstrates that EPM1 is a neurodegenerative disease and that cystatin B is necessary to prevent apoptosis in cerebellar granule cells.
34. Fujita N, Suzuki K, Vanier MT, Popko B, Maeda N, Klein A, Sandhoff K, Nakayasu H, Suzuki K: Genetic sphingoloid activator protein (SAP) deficiencies in human and a 'knockout' mouse. J Neurochem 1996, 66(suppl1):S1.
35. Campbell IL, Carmela RA, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L: Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993, 90:10061-10065.
36. Sisodia S, Thinakaran G, Koch CV, Slunt H, Kitt C, Reed R, Roskams J, Ronnett G, Zheng H, Ploeg LVD, Price D: In vivo analysis of APP and APLP2 function. J Neurochem 1996, 66(suppl 1): S53.
37. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP: Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
38. Ordway JM, Tallaksen-Greene S, Gutekunst CA, Bernstein EM, Cearley JA, Wiener WH, Dure LS, Lindsey R, Hersch SM, Jope RS et al.: Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 1997, 91 :753-763.
39. Kokaia M, Ernfors P, Kokaia Z, Elmer E, Jaenisch R, Lindvall O: Suppressed epileptogenesis in BDNF mutant mice. Exp Neurol 1995, 133:215-224.
40. Cain DP, Grant SGN, Saucier D, Hargreaves EL, Kandel ER: Fyn tyrosine kinase is required for normal amygdala kindling. Epilepsy Res 1995, 22:107-114.
41. Tsirka SE, Gualandris A, Amaral DG, Strickland S: Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995, 377:340-344.
42. Watanabe Y, Johnson RS, Butler LS, Binder DK, Spiegelman BM, Papaioannou V, McNarnara JO: Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy. J Neurosci 1996, 16:3827-3836.
43. Erickson JC, Hollopeter G, Thomas SA, Froelick GJ, Palmiter RD: Disruption of the metallothionein-III gene in mice: Analysis of brain zinc, behavior, and neuron vulnerability to metals, aging and seizures. J Neurosci 1997, 17:1271 -1281.
44. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy JD, Hawkes R, Frankel WN, Copeland NG, Jenkins NA: Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996, 87:607-617.
45. 2+ channel β subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (Ih) mouse. Cell 1997, 88:385-392.
46. 2+-channel γ subunit. Nat Gene 1998, 19:340-347. This paper reports the identification of a new neuronal calcium channel subunit with structural similarity to the γ subunit of skeletal muscle voltage-gated calcium channel. Mutations in this gene have been shown to be responsible for the stargazer phenotype, a mouse model for human absence epilepsy.
47. Cox GA, Lutz CM, Yang CL, Biemesderfer D, Bronson RT, Fu A, Aronson PS, Noebels JL, Frankel WN: Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice. Cell 1997, 91:139-148.
48. Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS: A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat Genet 1995, 11:126-129.
49. Street VA, Bosma MM, Demas VO, Regan MR, Lin DD, Robinson LC, Agnew WS, Temple BL: The type 1 inositol 1,4,5-triphosphate receptor gene is altered in the opisthotonos mouse. J Neurosci 1997, 17:635-645.
50. Wuarin JP, Dudek FE: Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated rats. J Neurosci 1996, 16:4438-4448.
51. Zheng D, Butler LS, McNamara JO: Kindling and associated mossy fibre sprouting are not affected in mice deficient of NGFI-A/NGFI-B genes. Neuroscience 1998, 83:251-258.
52. Ernfors P, Bengzon J, Kokaia Z, Persson H, Lindvall O: Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 1991, 7:165-176.
53. Binder DK, Routbort MJ, Ryan TE, Yancopoulos GD, McNamara JO: Selective inhibition of kindling development by intraventricular administration of TrkB receptor body. J Neurol Sci 1999, 19:1424-1436. This paper demonstrates the importance of neurotrophins in epileptogenesis. By using highly specific reagents delivered to the adult brain, the experiments provide strong evidence that TrkB receptor activation is important in the development of kindling, an animal model of human epilepsy.
54. Ptacek LJ: The place of migraine as a channelopathy. Curr Opin Neurol 1998, 11:217-226. An excellent review article that discusses the role of mutant ion channels in episodic human disorders. The author discusses the usefulness of molecular characterization of rare and monogenic episodic disorders to understand more common and complex disorders such as epilepsy and migraine.
55. 2+ channel CACNL1A4. Cell 1996, 87:543-552.
56. + antiporter, glycoprotein of 110 kD. Science 1990, 247:723-726.
57. Gurney ME: Transgenic animal models of familial amyotrophic lateral sclerosis. J Neurol 1997, 244(suppl 2):S15-S20.
58. Price DL, Sisodia SS, Borchelt, DR: Genetic neurodegenerative diseases: The human illness and transgenic models. Science 1998, 282:1079-1083.
59. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneve K, Miao J, D'Amato E, Ramirez L, Faham M, Koskiniemi M et al.: Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy. Science 1996, 271:1731 -1734.
60. Zuo J, de Jager PL, Takahashi KA, Jiang W, Linden DJ, Heintz N: Neurodegeneration in Lurcher mice caused by mutation in δ2 glutamate receptor gene. Nature 1997, 388:769-773.
61. Seyfried TN, Todorova M: Experimental models of epilepsy. In The Epilepsies: Etiologies and Prevention. Edited by Kotagal P, Luders HO. San Diego: Academic Press; 1999:527-542. This article presents a detailed description of all the animal models of epilepsy, with emphasis on the individual phenotype exhibited. The genetic convulsive disorders in mice are described in detail and the usefulness of studying animal models to understand human disease is emphasized.